相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The relationship between antihypertensive medications and mood disorders: analysis of linked healthcare data for 1.8 million patients
Richard J. Shaw et al.
PSYCHOLOGICAL MEDICINE (2021)
The Angiotensin Type 1 Receptor Antagonist Losartan Prevents Ovariectomy-Induced Cognitive Dysfunction and Anxiety-Like Behavior in Long Evans Rats
Glenda Campos et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
Differential expression of angiotensin II type 1 receptor subtypes within the cerebral microvasculature
Evan Yamasaki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics
David Gurwitz
DRUG DEVELOPMENT RESEARCH (2020)
Candesartan Neuroprotection in Rat Primary Neurons Negatively Correlates with Aging and Senescence: a Transcriptomic Analysis
Abdel G. Elkahloun et al.
MOLECULAR NEUROBIOLOGY (2020)
Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor
Carl-Mikael Suomivuori et al.
SCIENCE (2020)
COVID-19, Angiotensin Receptor Blockers, and the Brain
Juan M. Saavedra
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension A Single-Center Retrospective Study
Guang Yang et al.
HYPERTENSION (2020)
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Julie Helms et al.
INTENSIVE CARE MEDICINE (2020)
Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury
Riccardo Sarzani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
AngiotensinIIreceptors: Impact forCOVID-19 severity
Hasan Aksoy et al.
DERMATOLOGIC THERAPY (2020)
Influence of Renin-Angiotensin System Inhibitors on Lower-Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
Timothy M. E. Davis et al.
DIABETES CARE (2020)
The Role of the Renin‐Angiotensin System in Skin Physiology and Pathophysiology
Igor Maciel Souza Silva et al.
EXPERIMENTAL DERMATOLOGY (2020)
Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation
Brennan J. Wadsworth et al.
CANCER LETTERS (2020)
Role of the renin-angiotensin-aldosterone system in bone metabolism
Caiyan Mo et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2020)
Angiotensin Receptor Blockers Associated with Improved Breast Cancer Survival-A Nationwide Cohort Study from Finland
Eerik E. E. Santala et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Angiotensin receptor blockers and COVID-19
Juan M. Saavedra
PHARMACOLOGICAL RESEARCH (2020)
COVID-19 is, in the end, an endothelial disease
Peter Libby et al.
EUROPEAN HEART JOURNAL (2020)
Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels
P. Demelo-Rodriguez et al.
THROMBOSIS RESEARCH (2020)
Candesartan could ameliorate the COVID-19 cytokine storm
Abdel G. Elkahloun et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?
Natella Maglakelidze et al.
PULMONARY THERAPY (2020)
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
Juan Meng et al.
EMERGING MICROBES & INFECTIONS (2020)
Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPAR Activation
Abdel G. Elkahloun et al.
MOLECULAR NEUROBIOLOGY (2019)
The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy
SeungJu Jackie Oh et al.
CNS DRUGS (2019)
MAPK/AP-1 pathway activation mediates AT1R upregulation and vascular endothelial cells dysfunction under PM2.5 exposure
Xiuduan Xu et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2019)
Angiotensin II Receptor 1 Blockage Limits Brain Damage and Improves Functional Outcome After Brain Injury in Aged Animals Despite Age-Dependent Reduction in AT1 Expression
Ralph Timaru-Kast et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2019)
The Role of Estrogen in Brain and Cognitive Aging
Jason K. Russell et al.
NEUROTHERAPEUTICS (2019)
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
Lauren B. Arendse et al.
PHARMACOLOGICAL REVIEWS (2019)
Letter to the Editor regarding A microanalytical capillary electrophoresis mass spectrometry assay for quantifying angiotensin peptides in the brain
A. H. Jan Danser et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2019)
Platelet TLR4 at the crossroads of thrombosis and the innate immune response
Mirta Schattner
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Clinician-initiated research on treating the host response to pandemic influenza
David S. Fedson
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Angiotensin generation in the brain: a re-evaluation
Estrellita Uijl et al.
CLINICAL SCIENCE (2018)
The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review
Luciana M. A. Borem et al.
HYPERTENSION RESEARCH (2018)
Valsartan attenuates bleomycin-induced pulmonary fibrosis by inhibition of NF-κB expression and regulation of Th1/Th2 cytokines
Hoda Mojiri-Forushani et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2018)
Evidence of altered depression and dementia-related proteins in the brains of young rats after ovariectomy
Ying-Yan Fang et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
Ana I. Rodriguez-Perez et al.
NEUROTHERAPEUTICS (2018)
The antibody horror show: an introductory guide for the perplexed
Simon. L. Goodman
NEW BIOTECHNOLOGY (2018)
Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study
Jiunn-Horng Kang et al.
PLOS ONE (2018)
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
Chih-Cheng Lai et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment
Kenta Nakamura et al.
CANCER SCIENCE (2018)
Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation
Sonia Villapol
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Future drug discovery in renin-angiotensin-aldosterone system intervention
Maria Tamargo et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Brain Renin-Angiotensin System Does It Exist?
Bibi S. van Thiel et al.
HYPERTENSION (2017)
Beneficial effects of Angiotensin II receptor blockers in brain disorders
J. M. Saavedra
PHARMACOLOGICAL RESEARCH (2017)
Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism
Takanobu Takezako et al.
PHARMACOLOGICAL RESEARCH (2017)
Memory is preserved in older adults taking AT1 receptor blockers
Jean K. Ho et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus
Vinicia Campana Biancardi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Local renin-angiotensin system mediates endothelial dilator dysfunction in aging arteries
Sheila Flavahan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
Candesartan ameliorates impaired fear extinction induced by innate immune activation
Maria M. Quinones et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice
Yongjun Xu et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease
Juan M. Saavedra
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration
Jose L. Labandeira-Garcia et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2016)
Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders
Angela H. Boal et al.
HYPERTENSION (2016)
Palmitoyl acyltransferase DHHC21 mediates endothelial dysfunction in systemic inflammatory response syndrome
Richard S. Beard et al.
NATURE COMMUNICATIONS (2016)
An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease
Abdel G. Elkahloun et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
The association of renin-angiotensin system blockades and pneumonia requiring admission in patients with COPD
Junghyun Kim et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank
Kevin F. Bieniek et al.
ACTA NEUROPATHOLOGICA (2015)
Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease
Sandra I. Mota et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Neurorestoration after traumatic brain injury through angiotensin II receptor blockage
Sonia Villapol et al.
BRAIN (2015)
Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of conditioned fear1
R. C. Hurt et al.
GENES BRAIN AND BEHAVIOR (2015)
PPARγ-Dependent and -Independent Inhibition of the HMGB1/TLR9 Pathway by Eicosapentaenoic Acid Attenuates Ischemic Brain Damage in Ovariectomized Rats
Manabu Sumiyoshi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
Telmisartan attenuated LPS-induced neuroinflammation in human IMR-32 neuronal cell line via SARM in AT1R independent mechanism
Prathab Balaji Saravanan et al.
LIFE SCIENCES (2015)
Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension
Intira Sriprasert et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2015)
ESTROGEN EFFECTS ON COGNITIVE AND SYNAPTIC HEALTH OVER THE LIFECOURSE
Yuko Hara et al.
PHYSIOLOGICAL REVIEWS (2015)
Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis
Jiaolong Wang et al.
SCIENTIFIC REPORTS (2015)
PPARγ-Dependent and -Independent Inhibition of the HMGB1/TLR9 Pathway by Eicosapentaenoic Acid Attenuates Ischemic Brain Damage in Ovariectomized Rats
Manabu Sumiyoshi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
Neuroprotective Effects of Angiotensin Receptor Blockers
Sonia Villapol et al.
AMERICAN JOURNAL OF HYPERTENSION (2015)
The Effects of Angiotensin II Signaling Blockade on Platelet Activity in Subjects with Hypertension
Nabeel Ahmed et al.
CURRENT HYPERTENSION REVIEWS (2015)
Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade
Daisuke Sueta et al.
ATHEROSCLEROSIS (2014)
Angiotensin Type 1 Receptor Inhibition Enhances the Extinction of Fear Memory
Paul J. Marvar et al.
BIOLOGICAL PSYCHIATRY (2014)
Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade
Waleed Barakat et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Allosteric Modulation of β-Arrestin-biased Angiotensin II Type 1 Receptor Signaling by Membrane Stretch
Wei Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Valsartan independent of AT1 receptor inhibits tissue factor, TLR-2 and-4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions
Yu Mi Ha et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Angiotensin II regulates testicular peritubular cell function via AT1 receptor: A specific situation in male infertility
H. Welter et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model
Brice Ongali et al.
NEUROBIOLOGY OF DISEASE (2014)
Telmisartan ameliorates glutamate-induced neurotoxicity: Roles of AT1 receptor blockade and PPARγ activation
Juan Wang et al.
NEUROPHARMACOLOGY (2014)
Roles of Coagulation and Fibrinolysis in Angiotensin II-Enhanced Microvascular Thrombosis
Elena Y. Senchenkova et al.
MICROCIRCULATION (2014)
Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study
Yen-Chieh Lee et al.
PLOS ONE (2014)
Risk of Hospitalization for Community Acquired Pneumonia with Renin-Angiotensin Blockade in Elderly Patients: A Population-Based Study
Sachin Shah et al.
PLOS ONE (2014)
Valsartan reverses depressive/anxiety-like behavior and induces hippocampal neurogenesis and expression of BDNF protein in unpredictable chronic mild stress mice
Gu Ping et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Amelioration of Systemic Fibrosis in Mice by Angiotensin II Receptor Blockade
Wioleta Marut et al.
ARTHRITIS AND RHEUMATISM (2013)
Depression and Parkinson's Disease: Current Knowledge
Laura Marsh
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers
Satoshi Imaizumi et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Antihypertensive and metabolic effects of high-dose olmesartan and telmisartan in type 2 diabetes patients with hypertension
Tadashi Arao et al.
ENDOCRINE JOURNAL (2013)
Lack of Specificity of Commercial Antibodies Leads to Misidentification of Angiotensin Type 1 Receptor Protein
Marcela Herrera et al.
HYPERTENSION (2013)
The Effects of Antihypertensive Drugs on Bone Mineral Density in Ovariectomized Mice
Kwi Young Kang et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2013)
Antihypertensive Therapy and Cerebral Hemodynamics in Executive Mild Cognitive Impairment: Results of a Pilot Randomized Clinical Trial
Ihab Hajar et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2013)
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Vikash P. Chauhan et al.
NATURE COMMUNICATIONS (2013)
Sweeten PAMPs: role of sugar complexed PAMPs in innate immunity and vaccine biology
Ranjeet Singh Mahla et al.
FRONTIERS IN IMMUNOLOGY (2013)
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
Martin C. Michel et al.
PHARMACOLOGICAL REVIEWS (2013)
RAS Inhibition Attenuates Cognitive Impairment by Reducing Blood-Brain Barrier Permeability in Hypertensive Subjects
Nicolas Pelisch et al.
CURRENT HYPERTENSION REVIEWS (2013)
The effect of endogenous angiotensin II on alveolar fluid clearance in rats with acute lung injury
Jia Deng et al.
CANADIAN RESPIRATORY JOURNAL (2012)
Six Commercially Available Angiotensin II AT1 Receptor Antibodies are Non-specific
Julius Benicky et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Population-Based Study of Statins, Angiotensin II Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors on Pneumonia-Related Outcomes
Eric M. Mortensen et al.
CLINICAL INFECTIOUS DISEASES (2012)
Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders
Juan M. Saavedra
CLINICAL SCIENCE (2012)
Delayed inhibition of angiotensin II receptor type 1 reduces secondary brain damage and improves functional recovery after experimental brain trauma
Ralph Timaru-Kast et al.
CRITICAL CARE MEDICINE (2012)
Compound 21 Induces Vasorelaxation via an Endothelium- and Angiotensin II Type 2 Receptor-Independent Mechanism
Koen Verdonk et al.
HYPERTENSION (2012)
The Renin-Angiotensin Pathway in Posttraumatic Stress Disorder: Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Are Associated With Fewer Traumatic Stress Symptoms
Nayla M. Khoury et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-gamma activation in human monocytes
Tao Pang et al.
JOURNAL OF HYPERTENSION (2012)
Telmisartan directly ameliorates the neuronal inflammatory response to IL-1β partly through the JNK/c-Jun and NADPH oxidase pathways
Tao Pang et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Candesartan, an Angiotensin II AT1-Receptor Blocker and PPAR-γ Agonist, Reduces Lesion Volume and Improves Motor and Memory Function After Traumatic Brain Injury in Mice
Sonia Villapol et al.
NEUROPSYCHOPHARMACOLOGY (2012)
The renin-angiotensin system and the gastrointestinal mucosa
L. Fandriks
ACTA PHYSIOLOGICA (2011)
Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB Trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE)
Yutaka Mori et al.
ADVANCES IN THERAPY (2011)
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good
Ping Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
Lower Frequency of Antidepressant Use in Patients on Renin-Angiotensin-Aldosterone System Modifying Medications
Suhayl J. Nasr et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2011)
Endothelial Cell-Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II-Induced Ascending Aortic Aneurysms in LDL Receptor-/- Mice
Debra L. Rateri et al.
CIRCULATION RESEARCH (2011)
Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy
Vincent T. Marchesi
FASEB JOURNAL (2011)
Associations of Anti-Hypertensive Treatments with Alzheimer's Disease, Vascular Dementia, and Other Dementias
Neil M. Davies et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Angiotensin II type 1 receptor blockers: class effects versus molecular effects
Shin-ichiro Miura et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2011)
Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation
Julius Benicky et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
Benjamin Diop-Frimpong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Angiotensin II type 1 receptor blockers improve insulin sensitivity in patients with schizophrenia being treated with olanzapine
Hakuei Yamashita et al.
PSYCHOPHARMACOLOGY (2011)
Linking Molecules to Mood: New Insight Into the Biology of Depression
Vaishnav Krishnan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Expression of miR-I 46a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-I 46a/b and Toll-like receptor 4 levels
Yuji Takahashi et al.
CLINICAL SCIENCE (2010)
Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets
Filippo Caraci et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
The Angiotensin II Type 1 Receptor Antagonist Olmesartan Preserves Cerebral Blood Flow and Cerebrovascular Reserve Capacity, and Accelerates Rehabilitative Outcomes in Hypertensive Patients with a History of Stroke
Shuji Matsumoto et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2010)
Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction
Min-A Yu et al.
JOURNAL OF HYPERTENSION (2010)
Blocking Angiotensin II Type 1 Receptor Triggers Apoptotic Cell Death in Human Pancreatic Cancer Cells
Qiaoke Gong et al.
PANCREAS (2010)
Angiotensin receptors as determinants of life span
Paola Cassis et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Losartan, an antagonist of AT(1) receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat
Ling Liu et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo
Mohan R. Dasu et al.
ATHEROSCLEROSIS (2009)
Candesartan attenuates Angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway
Jinlei Lv et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
In vivo Angiotensin II AT(1) receptor blockade selectively inhibits LPS-induced innate immune response and ACTH release in rat pituitary gland
Enrique Sanchez-Lemus et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Vascular and metabolic effects of angiotensin II receptor blockers
Silvia Barra et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Disruption of the Ang II type 1 receptor promotes longevity in mice
Ariela Benigni et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Effects of angiotensin on the expression of fibrosis-associated cytokines, growth factors, and matrix proteins in human lung fibroblasts
M. Okada et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2009)
A Guide to the Perplexed on the Specificity of Antibodies
Clifford B. Saper
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes
Ignacio M. Larrayoz et al.
JOURNAL OF HYPERTENSION (2009)
Menopause and Ovariectomy Cause a Low Grade of Systemic Inflammation that May Be Prevented by Chronic Treatment with Low Doses of Estrogen or Losartan
May Abu-Taha et al.
JOURNAL OF IMMUNOLOGY (2009)
The synergistic induction of cyclooxygenase-2 in lung fibroblasts by angiotensin II and pro-inflammatory cytokines
Takaya Matsuzuka et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
NEURONAL AND GLIAL CELL EXPRESSION OF ANGIOTENSIN II TYPE 1 (AT1) AND TYPE 2 (AT2) RECEPTORS IN THE RAT RETINA
L. E. Downie et al.
NEUROSCIENCE (2009)
The Effect of Ovariectomy and Estrogen on Penetrating Brain Arterioles and Blood-Brain Barrier Permeability
Marilyn J. Cipolla et al.
MICROCIRCULATION (2009)
Seven decades of angiotensin (1939-2009)
Ranko Skrbic et al.
PEPTIDES (2009)
Increased Angiotensin II AT1 receptor mRNA and binding in spleen and lung of AT2 receptor gene disrupted mice
Jaroslav Pavel et al.
REGULATORY PEPTIDES (2009)
Stress, depression and cardiovascular dysregulation: A review of neurobiological mechanisms and the integration of research from preclinical disease models
Angela J. Grippo et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2009)
A Systematic Review of Angiotensin Receptor Blockers in Preventing Stroke
Guo-Cai Lu et al.
STROKE (2009)
Angiotensin II AT1 receptor blockade decreases lipopolysaccharide-induced inflammation in the rat adrenal gland
Enrique Sanchez-Lemus et al.
ENDOCRINOLOGY (2008)
Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators
Bruce S. McEwen
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Effect of telmisartan on nitric oxide-asymmetrical dimethylarginine system -: Role of angiotensin II type 1 receptor and peroxisome proliferator activated receptor γ signaling during endothelial aging
Fortunato Scalera et al.
HYPERTENSION (2008)
Losartan attenuates ventilator-induced lung injury
Shanglong Yao et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Candesartan and cognitive decline in older patients with hypertension - A substudy of the SCOPE trial
B. K. Saxby et al.
NEUROLOGY (2008)
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
Hymie Anisman et al.
PROGRESS IN NEUROBIOLOGY (2008)
Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats
C. Bregonzio et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2008)
Role of the renin-angiotensin system in vascular inflammation
Chiara Marchesi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: A pilot study
Munechika Enjoji et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2008)
Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral Hemorrhage
Keun-Hwa Jung et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Antihypertensives as novel antineoplastics: Angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma
Hwyda A. Arafat et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)
Estrogen and isoflavone attenuate stress-induced gastric mucosal injury by inhibiting decreases in gastric tissue levels of CGRP in ovariectomized rats
Nobuhiko Shimozawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
Richard B. Devereux et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Brain and peripheral angiotensin II play a major role in stress
Juan M. Saavedra et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2007)
Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions
Carmine Savoia et al.
CLINICAL SCIENCE (2007)
Effects of olmesartan, an AT1 receptor antagonist, on hypoxia-induced activation of ERK1/2 and pro-inflammatory signals in the mouse lung
Yoshiyuki Tanabe et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Effects of candesartan for middle-aged and elderly women with hypertension and menopausal-like symptoms
Hideo Ikeda et al.
HYPERTENSION RESEARCH (2006)
Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus
Anantha Shekhar et al.
JOURNAL OF NEUROSCIENCE (2006)
Expression and regulation of AT1 receptor in rat lung microvascular endothelial cell
Hong Zhang et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Physiology of local renin-angiotensin systems
Martin Paul et al.
PHYSIOLOGICAL REVIEWS (2006)
Feasibility of treating prehypertension with an angiotensin-receptor blocker
S Julius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) - A review
A Zanchetti et al.
BLOOD PRESSURE (2006)
AT1 receptor antagonism improves endothelial dysfunction in postmenopausal women
K Wassmann et al.
MATURITAS (2006)
A centrally acting, anxiolytic angiotensin II AT(1) receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding
Juan M. Saavedra et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Molecular activation of PPAR gamma by angiotensin II type 1-receptor antagonists
David V. Erbe et al.
VASCULAR PHARMACOLOGY (2006)
LPS induces permeability injury in lung microvascular endothelium via AT1 receptor
H Zhang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats
J Zhou et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists
JM Saavedra et al.
REGULATORY PEPTIDES (2005)
Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension?
JL Reid
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2005)
Minocycline treatment attenuates microglia activation and non-angiotensin II[I-125]CGP42112 binding in brainstem following nodose ganglionectomy
CL Roulston et al.
NEUROSCIENCE (2005)
Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension
R Fogari et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats
H Ando et al.
STROKE (2004)
Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women
R Fogari et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Effect of antihypertensive agents on quality of life in the elderly
R Fogari et al.
DRUGS & AGING (2004)
Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury
C Bregonzio et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome
S Raiden et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats
Y Mukai et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist
T Ito et al.
STROKE (2002)
Increased angiotensin II AT1 receptor expression in paraventricular nucleus and hypothalamic-pituitary-adrenal axis stimulation in AT2 receptor gene disrupted mice
I Armando et al.
NEUROENDOCRINOLOGY (2002)
Angiotensin receptor subtype AT1 mediates alveolar epithelial cell apoptosis in response to ANG II
M Papp et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Effect of losartan in aging-related endothelial impairment
S Rajagopalan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling
M Schwemmer et al.
CARDIOVASCULAR DRUGS AND THERAPY (2001)
Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats
Y Nishimura et al.
STROKE (2000)
Effects of valsartan and 17β-estradiol on the oxidation of low-density lipoprotein in vitro
H Seeger et al.
CORONARY ARTERY DISEASE (2000)
Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats
W Linz et al.
HYPERTENSION (2000)
Chronic overproduction of transforming growth factor-beta 1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice
T Wyss-Coray et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Localization and function of angiotensin AT(1) receptors
AM Allen et al.
AMERICAN JOURNAL OF HYPERTENSION (2000)
分享论文
